Crossref journal-article
Elsevier BV
Kidney International (78)
Bibliography

Rappaport, J., Hanss, B., Kopp, J. B., Copeland, T. D., Bruggeman, L. A., Coffman, T. M., & Klotman, P. E. (1995). Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapy. Kidney International, 47(5), 1462–1469.

Authors 7
  1. Jay Rappaport (first)
  2. Basil Hanss (additional)
  3. Jeffrey B. Kopp (additional)
  4. Terry D. Copeland (additional)
  5. Leslie A. Bruggeman (additional)
  6. Thomas M. Coffman (additional)
  7. Paul E. Klotman (additional)
References 58 Referenced 114
  1. {'key': '10.1038/ki.1995.205_bb0010', 'first-page': '647', 'article-title': 'In vitro and in vivo pharmacologic activities of antisense oligonucleotides', 'volume': '6', 'author': 'Mirabelli', 'year': '1991', 'journal-title': 'Anticancer Drug Des'} / Anticancer Drug Des / In vitro and in vivo pharmacologic activities of antisense oligonucleotides by Mirabelli (1991)
  2. 10.1096/fasebj.7.6.7682523 / FASEB J / Progress toward oligonucleotide therapeutics: Pharmacodynamic properties by Crooke (1993)
  3. 10.1093/nar/19.5.1113 / Nucl Acids Res / Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism by Boiziau (1991)
  4. 10.1016/S0021-9258(19)49937-7 / J Biol Chem / Modulation of eucaryotic initiation factor-4E binding to 5′-capped oligoribonucleotides by modified anti-sense oligonucleotides by Baker (1992)
  5. 10.1126/science.8351515 / Science / Antisense oligonucleotides as therapeutic agents—Is the bullet really magical by Stein (1993)
  6. {'key': '10.1038/ki.1995.205_bb0035', 'series-title': 'Int Union of Biochemistry Conf on Nucleic Acid Therapeutics', 'first-page': '71', 'article-title': 'Synthesis and biophysical studies of 2′-d-ribo-f modified oligonucleotides', 'author': 'Kawasaki', 'year': '1991'} / Int Union of Biochemistry Conf on Nucleic Acid Therapeutics / Synthesis and biophysical studies of 2′-d-ribo-f modified oligonucleotides by Kawasaki (1991)
  7. {'key': '10.1038/ki.1995.205_bb0040', 'first-page': '1157', 'article-title': '[Mechanism for suppression mRNA translation with antisense oligonucleotides]', 'volume': '24', 'author': 'Vlasov', 'year': '1990', 'journal-title': 'Mol Biol (Moskow)'} / Mol Biol (Moskow) / [Mechanism for suppression mRNA translation with antisense oligonucleotides] by Vlasov (1990)
  8. 10.1128/jvi.67.11.6882-6888.1993 / J Virol / Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Revresponsive element by Li (1993)
  9. 10.1073/pnas.85.15.5507 / Proc Natl Acad Sci USA / Inhibition of human immunodeficiency virus replication by anti-sense oligodeoxynucleotides by Goodchild (1988)
  10. 10.1089/ard.1992.2.261 / Antisense Res Dev / GEM 91—An antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS by Agrawal (1992)
  11. 10.1126/science.2897717 / Science / Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin by Jaskulski (1988)
  12. 10.1126/science.2218499 / Science / Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer by Maier (1990)
  13. 10.1093/nar/19.12.3359 / Nucl Acids Res / Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element by Vickers (1991)
  14. 10.1073/pnas.90.3.1023 / Proc Natl Acad Sci USA / The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus by Doerre (1993)
  15. 10.1128/AAC.37.2.171 / Antimicrob Agents Chemother / In vitro evaluation of phosphorothioate oligonucleotides targeted to the E2 mRNA of papillomavirus: Potential treatment for genital warts by Cowsert (1993)
  16. 10.1126/science.2237444 / Science / Regulation of gene expression with double-stranded phosphorothioate oligonucleotides by Bielinska (1990)
  17. 10.1073/pnas.88.4.1516 / Proc Natl Acad Sci USA / Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor beta 3 by Potts (1991)
  18. 10.1073/pnas.89.24.11823 / Proc Natl Acad Sci USA / In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides by Ratakczal (1992)
  19. 10.1126/science.1299224 / Science / Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B by Kitajima (1992)
  20. {'key': '10.1038/ki.1995.205_bb0105', 'first-page': '849', 'article-title': 'Antisense oligonucleotides as potential antiviral and anticancer agents', 'volume': '76', 'author': 'Le Doan', 'year': '1989', 'journal-title': 'Bull Cancer (Paris)'} / Bull Cancer (Paris) / Antisense oligonucleotides as potential antiviral and anticancer agents by Le Doan (1989)
  21. 10.1038/bjc.1991.3 / Br J Cancer / Synthetic oligonucleotides as therapeutic agents by Tidd (1991)
  22. 10.1089/ard.1992.2.109 / Antisense Res Dev / Systemic human antisense therapy begins by Bayever (1992)
  23. 10.1016/0305-7372(93)90033-N / Cancer Treat Rev / Prospects for gene-directed therapy with antisense oligodeoxynucleotides by Calabretta (1993)
  24. {'key': '10.1038/ki.1995.205_bb0125', 'first-page': '539', 'article-title': 'Phosphorothioate oligonucleotides: Chemistry, purification, analysis, scale-up and future directions', 'volume': '6', 'author': 'Zon', 'year': '1991', 'journal-title': 'Anticancer Drug Des'} / Anticancer Drug Des / Phosphorothioate oligonucleotides: Chemistry, purification, analysis, scale-up and future directions by Zon (1991)
  25. 10.1021/bi00081a031 / Biochemistry / Oligodeoxynucleotides containing 2′-O-modified adenosine: Synthesis and effects on stability of DNA:RNA duplexes by Lesnik (1993)
  26. 10.1093/nar/19.11.2979 / Nucl Acids Res / Duplex stabilities of phosphorothioate, methylphosphonate, and RNA analogs of two DNA 14-mers by Kibler-Herzog (1991)
  27. 10.1093/nar/21.11.2729 / Nucl Acids Res / Self-stabilized antisense oligodeoxynucleotide phosphorothioates: Properties and anti-HIV activity by Tang (1993)
  28. 10.1093/jnci/81.20.1539 / J Natl Cancer Inst / Oligodeoxynucleotides as anti-sense inhibitors of gene expression: Therapeutic implications by Rothenberg (1989)
  29. 10.1089/ard.1993.3.53 / Antisense Res Dev / Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides by Zhao (1993)
  30. 10.1089/ard.1992.2.17 / Antisense Res Dev / Analysis of oligonucleotide binding, internalization, and intracellular trafficking utilizing a novel radiolabeled crosslinker by Geselowitz (1992)
  31. 10.1073/pnas.86.10.3474 / Proc Natl Acad Sci USA / Characterization of oligonucleotide transport into living cells by Loke (1989)
  32. {'key': '10.1038/ki.1995.205_bb0165', 'series-title': 'Nucl Acids Symp Ser', 'first-page': '311', 'article-title': 'Interaction of oligonucleotides with cellular receptors', 'author': 'Yakubov', 'year': '1991'} / Nucl Acids Symp Ser / Interaction of oligonucleotides with cellular receptors by Yakubov (1991)
  33. {'key': '10.1038/ki.1995.205_bb0170', 'first-page': '962', 'article-title': '[Affinity modification of proteins, binding nucleic acids in mammalian cells, by alkylating derivatives of oligonucleotides]', 'volume': '58', 'author': 'Vlasov', 'year': '1993', 'journal-title': 'Biokhimiia'} / Biokhimiia / [Affinity modification of proteins, binding nucleic acids in mammalian cells, by alkylating derivatives of oligonucleotides] by Vlasov (1993)
  34. {'key': '10.1038/ki.1995.205_bb0175', 'first-page': '1091', 'article-title': 'Rapid nuclear accumulation of injected oligodeoxyribonucleotides', 'volume': '2', 'author': 'Chin', 'year': '1990', 'journal-title': 'New Biol'} / New Biol / Rapid nuclear accumulation of injected oligodeoxyribonucleotides by Chin (1990)
  35. 10.1073/pnas.88.7.2702 / Proc Natl Acad Sci USA / Intracellular distribution of microinjected antisense oligonucleotides by Leonetti (1991)
  36. {'key': '10.1038/ki.1995.205_bb0185', 'series-title': 'Nucl Acids Symp Ser', 'first-page': '147', 'article-title': 'Nuclear location of synthetic oligonucleotides microinjected somatic cells: Its implication in an antisense strategy', 'author': 'Mechti', 'year': '1991'} / Nucl Acids Symp Ser / Nuclear location of synthetic oligonucleotides microinjected somatic cells: Its implication in an antisense strategy by Mechti (1991)
  37. 10.1111/1523-1747.ep12371683 / J Invest Dermatol / Characteristics of oligonucleotide uptake in human keratinocyte cultures by Noonberg (1993)
  38. 10.1073/pnas.86.17.6454 / Proc Natl Acad Sci USA / Mechanism of oligonucleotide uptake by cells: Involvement of specific receptors by Yakubov (1989)
  39. 10.1111/1523-1747.ep12875170 / J Invest Dermatol / Identification of a cell-surface DNA receptor and its association with systemic lupus erythematosus by Hefeneider (1990)
  40. 10.1177/096120339200100308 / Lupus / DNA binding to mouse cells is mediated by cell-surface molecules: The role of these DNA-binding molecules as target antigens in murine lupus by Hefeneider (1992)
  41. 10.1073/pnas.88.17.7595 / Proc Natl Acad Sci USA / Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice by Agrawal (1991)
  42. 10.1002/bdd.2510130308 / Biopharm Drug Dispos / Organ distribution and stability of phosphorothioated oligodeoxyribonucleotides in mice by Goodarzi (1992)
  43. {'key': '10.1038/ki.1995.205_bb0220', 'first-page': '1181', 'article-title': 'Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats', 'volume': '267', 'author': 'Cossum', 'year': '1993', 'journal-title': 'J Pharmacol Exp Ther'} / J Pharmacol Exp Ther / Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats by Cossum (1993)
  44. 10.1097/00007890-199311000-00021 / Transplantation / Alterations in renal interleukin-1 production during kidney transplant rejection in the rat. The effects of high-dose methylprednisolone by Mannon (1993)
  45. 10.1016/0003-2697(90)90521-A / Anal Biochem / Preparation of 35S-labeled polyphosphorothioate oligodeoxyribonucleotides by use of hydrogen phosphonate chemistry by Stein (1990)
  46. 10.3109/09687687809063848 / Membr Biochem / Properties of brush border vesicles isolated from rat kidney cortex by calcium precipitation by Evers (1978)
  47. {'key': '10.1038/ki.1995.205_bb0240', 'first-page': '1497', 'article-title': 'A novel sequence in the type IV collagen promoter binds nuclear proteins from Engelbreth-Holm-Swarm tumor', 'volume': '7', 'author': 'Bruggeman', 'year': '1992', 'journal-title': 'Oncogene'} / Oncogene / A novel sequence in the type IV collagen promoter binds nuclear proteins from Engelbreth-Holm-Swarm tumor by Bruggeman (1992)
  48. 10.1089/ard.1991.1.153 / Antisense Res Dev / The clearance and degradation of oligodeoxynucleotides following intravenous injection into rabbits by Goodchild (1991)
  49. 10.1021/bi00843a023 / Biochemistry / Kinetics of the photochemical addition of 35S cysteine to polynucleotides and nucleic acids by Smith (1968)
  50. 10.1159/000207812 / Acta Haematol / Binding of deoxyribonucleic acid to the surface of human platelets by Clejan (1977)
  51. 10.1172/JCI112226 / J Clin Invest / DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA by Bennett (1985)
  52. 10.1016/S0378-4347(00)82193-3 / J Chromatogr / High performance liquid chromatographic analysis of phosphorothioate analogues of oligodeoxynucleotides in biological fluids by Bigelow (1990)
  53. 10.1016/S0021-9258(18)35691-6 / J Biol Chem / Human T-cell leukemia virus type I tax transformation is associated with increased uptake of oligodeoxynucleotides in vitro and in vivo by Kitajima (1992)
  54. 10.1089/ard.1992.2.223 / Antisense Res Dev / Binding of antisense phosphorothioate oligonucleotides to murine lymphocytes is lineage specific and inducible by Iversen (1992)
  55. 10.1073/pnas.80.8.2196 / Proc Natl Acad Sci USA / Cloning and sequence analysis of cDNA for rat angiotensinogen by Ohkubo (1990)
  56. 10.1016/0002-9343(91)80081-V / Am J Med / Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial by Gill (1991)
  57. 10.1016/0006-291X(91)92086-Y / Biochem Biophys Res Commun / Binding of oligonucleotides to cell membranes at acidic pH by Goodarzi (1991)
  58. U.M. Sarmiento J.R. Perez J.M. Becker R. Narayanan In vivo toxicological effects of rel A antisense phosphorothioates in CD-1 mice Antisense Res Dev (in press)
Dates
Type When
Created 18 years, 3 months ago (May 21, 2007, 1:49 p.m.)
Deposited 3 years, 9 months ago (Oct. 29, 2021, 6:59 p.m.)
Indexed 3 weeks, 4 days ago (Aug. 2, 2025, 12:41 a.m.)
Issued 30 years, 3 months ago (May 1, 1995)
Published 30 years, 3 months ago (May 1, 1995)
Published Print 30 years, 3 months ago (May 1, 1995)
Funders 0

None

@article{Rappaport_1995, title={Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapy}, volume={47}, ISSN={0085-2538}, url={http://dx.doi.org/10.1038/ki.1995.205}, DOI={10.1038/ki.1995.205}, number={5}, journal={Kidney International}, publisher={Elsevier BV}, author={Rappaport, Jay and Hanss, Basil and Kopp, Jeffrey B. and Copeland, Terry D. and Bruggeman, Leslie A. and Coffman, Thomas M. and Klotman, Paul E.}, year={1995}, month=may, pages={1462–1469} }